COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,833 Articles (22,553 medRxiv, 8,280 bioRxiv)

Most recent first Previous |  Page 231: Articles 2301-2310  | Next

Deciphering the Molecular Mechanism of Post-Acute Sequelae of COVID-19 through Comorbidity Network Analysis
Tian, L., Zhang, Q.
10.1101/2024.01.17.575851 — Posted: 2024-01-18
Sex and gender differences in adverse events following receipt of influenza and COVID-19 vaccination among healthcare workers
Yin, A., Wang, N., Shea, P. J., Rosser, E., Kuo, H., Shapiro, J. R., Fenstermacher, K. Z., Pekosz, A., Rothman, R. E., Klein, S. L., Morgan, R.
10.1101/2024.01.17.24301440 — Posted: 2024-01-18
Why did people not get vaccinated against COVID-19? Results from a nationwide survey among Mexican adults
Wrzecionkowska, D., Stephens, C. R., Gutierrez Reyes, J. P.
10.1101/2024.01.17.24301326 — Posted: 2024-01-17
Predicting COVID-19 Infection Among Older Syrian Refugees in Lebanon: A Multi-Wave Survey
Abi Zeid, B., El Khoury, T., Abdulrahim, S. R., Ghattas, H., McCall, S. J.
10.1101/2024.01.17.24301436 — Posted: 2024-01-17
Clinical Characteristics and Factors Associated with Long COVID in Zambia, August 2020 to January 2023
Malambo, W., Chanda, D., Besa, L., Engamba, D., Mwiinga, L., Mwitumwa, M., Matibula, P., Naik, N., Sivile, S., Agolory, S., Auld, A., Mulenga, L., Hines, J. Z., Fwoloshi, S.
10.1101/2024.01.17.24301423 — Posted: 2024-01-17
Impact of emerging SARS-CoV-2 on total and cause-specific maternal mortality: A natural experiment in Chile during the peak of the outbreak SARS-CoV-2 Impact on Maternal Mortality: Chiles Outbreak Study
Enriquez, Y., Critto, M. E., Weinberg, R., de Janon Quevedo, L., Galleguillos, A., Koch, E.
10.1101/2024.01.17.24301426 — Posted: 2024-01-17
Blood transcriptomics reveal persistent SARS-CoV-2 RNA and candidate biomarkers in Long COVID patients
MENEZES, S. M., JAMOULLE, M., Carletto, M. P., Van Holm, B., Moens, L., Meyts, I., Maes, P., Van Weyenbergh, J.
10.1101/2024.01.14.24301293 — Posted: 2024-01-17
Temporal changes in SARS-CoV-2 clearance kinetics and the optimal design of phase 2 antiviral studies
Wongnak, P., Schilling, W. H. K., Jittamala, P., Boyd, S. H. K., Luvira, V., Siripoon, T., Ngamprasertchai, T., Batty, E. M., Singh, S., Kouhathong, J., Pagornrat, W., Khanthagan, P., Hanboonkunupakarn, B., Poovorawan, K., Mayxay, M., Chotivanich, K., Imwong, M., Pukrittayakamee, S., Ashley, E. A., Dondorp, A. M., Day, N. P., Teixeira, M. M., Piyaphanee, W., Phumratanaprapin, W., White, N. J., Watson, J. A., PLATCOV Collaborative Group
10.1101/2024.01.16.24301342 — Posted: 2024-01-17
Pre-event psychiatric states predict trajectories of post-traumatic stress symptoms during the COVID-19 pandemic
Nakai, F., Kubo, T., Oka, T., Kobayashi, N., Tanichi, M., Murakami, M., Hamamura, T., Honjo, M., Miyake, Y., Ide, K., Cortese, A., Nagamine, M., Chiba, T.
10.1101/2024.01.14.23300571 — Posted: 2024-01-16
Heterogeneity in deaths of despair: excess mortality in the US during the Covid-19 pandemic
Kandula, S., Keyes, K. M., Shaman, J.
10.1101/2024.01.14.24301291 — Posted: 2024-01-16

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).